Use Case
Regulatory signal enhanced evidence review
This use case shows how external regulatory signals can support structured review of evidence packages, quality records, and selected medical device requirements.
Scenario
A quality and regulatory team is preparing a structured evidence package for a medical device product review. The team needs to map internal procedures, design records, and quality documentation against selected regulatory requirements, and wants to understand where external regulatory signals may add useful context to the review process.
This scenario illustrates how Tiebreaker AI can be used in a partner-enabled workflow where regulatory data is available alongside the internal evidence package.
Evidence reviewed
How Tiebreaker AI structures the review
Evidence files are uploaded into a Tiebreaker AI project. The selected frameworks are FDA 21 CFR Part 820 and FDA 510(k) evidence requirements. Tiebreaker AI extracts control-relevant content and maps each piece of documentation to the applicable requirement area.
Where regulatory signals may add context
In a partner-enabled workflow, external regulatory signals may be available alongside the internal evidence package. These signals can include recall histories, inspection observations, or requirement updates relevant to a specific product category or regulatory jurisdiction.
When integrated with partner data, Tiebreaker AI can surface whether the review areas flagged as missing or partial align with known regulatory areas of concern. This does not replace the review; it adds context to help the reviewer prioritize.
Important: Regulatory signal data in this scenario is partner-provided context. Tiebreaker AI does not provide regulatory advice or make compliance determinations. All outputs require human review and final decision by qualified personnel.
Human review and final decision control
Tiebreaker AI structures the evidence review and flags areas for follow-up. The AI does not make regulatory decisions, approve submissions, or determine compliance status. Every output is a structured input to human review.
Qualified reviewers retain full control over the assessment, follow-up actions, and any regulatory determination. Tiebreaker AI supports the review process; it does not replace expert judgment.
Premium and Partner / MSP relevance
Premium
Premium users can run full evidence reviews against FDA 21 CFR Part 820 and FDA 510(k) requirements. Access to the AI Compliance Assistant, Policy Assist, and structured readiness reporting is included at USD 799/month.
Partner / MSP
Partners and MSPs can deliver this workflow under their own brand with white-label reporting, repeatable review templates, and multi-client workspace management. Contact us to discuss Partner tier access.
Start a structured evidence review
Select FDA 21 CFR Part 820 or FDA 510(k) from the free access tier, or contact us to discuss a partner-enabled workflow.